🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

TD Cowen raises Aaron's shares target amid acquisition alignment

EditorEmilio Ghigini
Published 06/17/2024, 09:43 AM
AAN
-

On Monday, TD Cowen adjusted its outlook on Aaron's (NYSE:AAN) shares, a company operating in the lease-to-own sector. The firm increased the price target for Aaron's shares to $10.10, up from the previous target of $8.00, while keeping a Hold rating on the stock.

The adjustment follows a recent transaction that prompted the analyst to align the target price with the deal price of $10.10. Aaron's, along with its industry peer UPBD, shares a focus on the store-based lease-to-own business. However, the two companies differ significantly in their store formats and strategic directions regarding their store footages.

The analyst believes that Aaron's being acquired by a non-strategic buyer is a logical step, given the dynamics of the industry and the company's operations. This acquisition is seen as a move that aligns with the ongoing trends within the lease-to-own market.

Aaron's shares will now be watched with the updated price target in mind, as investors and market watchers assess the implications of the company's recent transaction and its impact on the stock's performance on the New York Stock Exchange.

In other recent news, The Aaron's Company is set to be acquired by IQVentures Holdings, LLC in a $504 million cash transaction that promises immediate value to shareholders.

The deal, unanimously approved by Aaron's Board of Directors, is expected to close by the year's end, pending shareholder and regulatory approvals. Post-acquisition, Aaron's will operate as a privately held entity, maintaining its brand identity and Atlanta headquarters.

In the realm of financial analysis, TD Cowen maintained a Hold rating on Aaron's shares but upgraded the price target from $7 to $8. This adjustment followed Aaron's first-quarter financial results, which showed an earnings per share (EPS) loss of $0.15. TD Cowen revised its EPS estimates for Aaron's for 2024 and 2025 to $0.25 and $0.84, respectively.

Aaron's first-quarter earnings for 2024 exhibited resilience and growth, despite a year-over-year decrease in consolidated revenues and adjusted EBITDA. The company raised its full-year outlook for non-GAAP diluted EPS, reflecting a lower estimated tax rate.

Aaron's also highlighted growth in its e-commerce channel and a smaller decline in its lease portfolio size, along with strong performance from its BrandsMart division. These are some of the recent developments in Aaron's Company.

InvestingPro Insights

As TD Cowen revises its price target for Aaron's, real-time data from InvestingPro provides additional context for investors considering the company's stock. Aaron's is currently trading at a low Price / Book multiple of 0.34, suggesting that the stock may be undervalued relative to its assets. This aligns with the firm's decision to maintain a Hold rating despite the price target increase. Moreover, the company's significant dividend yield of 6.63% is noteworthy for income-focused investors, especially considering Aaron's track record of raising its dividend for three consecutive years.

While Aaron's has faced challenges, with a 10.68% decline in revenue over the last twelve months as of Q1 2024 and a 29.63% drop in the 6-month price total return, analysts predict the company will return to profitability this year. This potential turnaround, coupled with the fact that Aaron's liquid assets exceed short-term obligations, offers a degree of financial stability. For those who wish to delve deeper into Aaron's financial health and future prospects, InvestingPro provides additional insights and tips, including 5 analysts who have revised their earnings downwards for the upcoming period. Discover more with a subscription, and use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. There are over 8 additional InvestingPro Tips available that could further inform investment decisions regarding Aaron's.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.